MARINUS PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Continuing Operations
MARINUS PHARMACEUTICALS, INC. reported Net Cash Provided by (Used in) Continuing Operations of -$3.60 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2017-05-01
- MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2017-03-31 was -$3.60M.
- MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2016-12-31 was -$6.72M, a 128.35% decline year-over-year.
- MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2016-09-30 was -$6.21M.
- MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2016-06-30 was -$7.63M.
- MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2016 was -$25.54M, a 1375.92% decline from fiscal 2015.
- MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2015 was $2.00M, a 94.96% decline from fiscal 2014.
- MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2014 was $39.68M, a 2728.44% increase from fiscal 2013.
- MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2013 was $1.40M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|---|---|
| 2017-03-31 | -$3.60M 10-Q · filed 2017-05-01 | -$10.32M derived: sum of 2 quarters · filed 2017-05-01 | -$16.53M derived: sum of 3 quarters · filed 2017-05-01 | -$24.15M derived: sum of 4 quarters · filed 2017-05-01 | ||
| 2016-12-31 | -$6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$12.92M derived: sum of 2 quarters · filed 2017-03-13 | -$20.55M derived: sum of 3 quarters · filed 2017-03-13 | -$25.54M 10-K · filed 2017-03-13 | ||
| 2016-09-30 | -$6.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$13.83M derived: sum of 2 quarters · filed 2016-11-08 | -$18.83M 10-Q · filed 2016-11-08 | $4.87M derived: sum of 4 quarters · filed 2017-05-01 | ||
| 2016-06-30 | -$7.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$12.62M 10-Q · filed 2016-08-09 | $11.07M derived: sum of 3 quarters · filed 2017-05-01 | $169.00K derived: sum of 4 quarters · filed 2017-05-01 | ||
| 2016-03-31 | -$4.99M 10-Q · filed 2017-05-01 | $18.70M derived: sum of 2 quarters · filed 2017-05-01 | $7.80M derived: sum of 3 quarters · filed 2017-05-01 | $2.25M derived: sum of 4 quarters · filed 2017-05-01 | ||
| 2015-12-31 | $23.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $12.79M derived: sum of 2 quarters · filed 2017-03-13 | $7.25M derived: sum of 3 quarters · filed 2017-03-13 | $2.00M 10-K · filed 2017-03-13 | ||
| 2015-09-30 | -$10.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$16.45M derived: sum of 2 quarters · filed 2016-11-08 | -$21.69M 10-Q · filed 2016-11-08 | -$19.08M derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2015-06-30 | -$5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$10.79M 10-Q · filed 2016-08-09 | -$8.17M derived: sum of 3 quarters · filed 2017-03-13 | $30.52M derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2015-03-31 | -$5.24M 10-Q · filed 2016-05-02 | -$2.63M derived: sum of 2 quarters · filed 2017-03-13 | $36.06M derived: sum of 3 quarters · filed 2017-03-13 | $35.65M derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2014-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $41.30M derived: sum of 2 quarters · filed 2017-03-13 | $40.89M derived: sum of 3 quarters · filed 2017-03-13 | $39.68M 10-K · filed 2017-03-13 | ||
| 2014-09-30 | $38.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $38.27M derived: sum of 2 quarters · filed 2015-10-29 | $37.07M 10-Q · filed 2015-10-29 | $37.07M 10-Q · filed 2014-11-13 | $34.44M derived: sum of 4 quarters · filed 2015-10-29 | |
| 2014-06-30 | -$414.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$1.62M 10-Q · filed 2015-08-04 | -$1.62M 10-Q · filed 2014-10-10 | -$4.25M derived: sum of 3 quarters · filed 2015-08-04 | -$5.45M derived: sum of 4 quarters · filed 2015-08-04 | |
| 2014-03-31 | -$1.21M 10-Q · filed 2015-05-14 | -$3.83M derived: sum of 2 quarters · filed 2015-05-14 | -$5.04M derived: sum of 3 quarters · filed 2015-05-14 | |||
| 2013-12-31 | -$2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$3.83M derived: sum of 2 quarters · filed 2015-03-12 | $1.40M 10-K · filed 2015-03-12 | |||
| 2013-09-30 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $4.03M 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | $5.23M 10-Q · filed 2014-10-10 |